Transglutaminase-mediated dual and site-specific incorporation of poly(ethylene glycol) derivatives into a chimeric interleukin-2

Bioconjugate Chemistry

Volumn 11, Issue 4, 2000, Pages 502-509

  Sato, Haruya ^a   Yamamoto, Keiji ^a   Hayashi, Eiko ^a   Takahara, Yoshiyuki ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CATALYSIS; ETHYLENE GLYCOL; PEPTIDES; POLYOLS; SUBSTRATES;

CHIMERIC PROTEINS; CLINICAL USE; GUINEA PIGS; INTERLEUKIN2 (IL2); NOVEL METHODS; PIG LIVER; PROTEIN CONJUGATES; SITE-SPECIFIC; SUBSTRATE PEPTIDES; TRANSGLUTAMINASES;

POLYETHYLENE GLYCOLS;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0033885714     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990148b     Document Type: Article

References (27)

1. Abuchowski, A., van Es, T., Palczuk, N. C., and Davis, F. F. (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of poly(ethylene glycol). J. Biol. Chem. 252 (11), 3578-3581.
2. Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., and Davis, F. F. (1977) Effect of covalent attachment of poly-(ethylene glycol) on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 252 (11), 3582-3586.
3. Sato, H., Watanabe, M., and Iwashita, Y. (1995) Synthesis and characterization of superoxide dismutase-deferoxamine conjugate via polyoxyethylene. Bioconjugate Chem. 6 (3), 249-254.
4. Zalipsky, S. (1995) Functionalized polyethylene glycol) for preparation of biologically relevant conjugates. Bioconjugate Chem. 6 (2), 150-165.
5. Dreborg, S., and Akerblom, E. B. (1990) Immunotherapy with monomethoxypoly(ethylene glycol) modified allergens. Crit. Rev. Ther. Drug. Carrier Syst. 6 (4), 315-365.
6. Burnham, N. L. (1994) Polymers for delivering peptides and proteins. Am. J. Hosp. Pharm. 51 (2), 210-218; quiz 228-229.
7. Katre, N. V. (1990) Immunogenicity of recombinant IL-2 modified by covalent attachment of poly(ethylene glycol). J. Immunol. 144 (1), 209-213.
8. Hershfield, M. S. (1995) PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin. Immunol. Immunopathol. 76 (3, Part 2), S228-232.
9. Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G., Hamburger, J. B., and Treuheit, M. J. ( 1996) Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 13 (7), 996-1002.
10. Goodson, R. J., and Katre, N. V. (1990) Site-directed pegylation of recombinant interleukin-2 at its glycosylation site. Biotechnology 8 (4), 343-346.
11. Woghiren, C., Sharma, B., and Stein, S. (1993) Protected thiol-poly(ethylene glycol): a new activated polymer for reversible protein modification. Bioconjugate Chem. 4 (5), 314-318.
12. Kuan, C. T., Wang, Q. C., and Pastan, I. (1994) Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with poly(ethylene glycol) in a site-specific manner. J. Biol. Chem. 269 (10), 7610-7616.
13. Benhar, I., Wang, Q. C., FitzGerald, D., and Pastan, I. (1994) Pseudomonas exotoxin A mutants. Replacement of surface-exposed residues in domain III with cysteine residues that can be modified with poly(ethylene glycol) in a site-specific manner. J. Biol. Chem. 269 (18), 13398-13404.
14. He, X. H., Shaw, P. C., Xu, L. H., and Tam, S. C. (1999) Site-directed poly(ethylene glycol) modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity. Life Sci. 64 (14), 1163-1175.
15. Gaertner, H. F., and Offord, R. E. (1996) Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins. Bioconjugate Chem. 7(1), 38-44.
16. Sato, H., Ikeda, M., Suzuki, K., and Hirayama, K. (1996) Site-specific modification of interleukin-2 by the combined use of genetic engineering techniques and transglutaminase. Biochemistry 35 (40), 13072-13080.
17. Beckman, J. S., Minor, R. L., Jr., White, C. W., Repine, J. E., Rosen, G. M., and Freeman, B. A. (1988) Superoxide dismutase and catalase conjugated to poly(ethylene glycol) increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 263 (14), 6884-6892.
18. Knauf, M. J., Bell, D. P., Hirtzer, P., Luo, Z. P., Young, J. D., and Katre, N. V. (1988) Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. J. Biol. Chem. 263 (29), 15064-15070.
19. Monfardini, C., Schiavon, O., Caliceti, P., Morpurgo, M., Harris, J. M., and Veronese, F. M. (1995) A branched monomethoxypoly(ethylene glycol) for protein modification. Bioconjugate Chem. 6(1), 62-69.
20. Tsuji, T., Nakagawa, R., Sugimoto, N., and Fukuhara, K. (1987) Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding. Biochemistry 26 (11), 3129-3134.
21. Gillis, S., Ferm, M. M., Ou, W., and Smith, K. A. (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120 (6), 2027-2032.
22. Yamaoka, K., and Nakagawa, T. (1983) A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J. Pharmacobiodyn. 6 (8), 595-606.
23. Kanwar, Y. S. (1984) Biophysiology of glomerular filtration and proteinuria. Lab. Invest. 51 (1), 7-21.
24. Deen, W. M., Satvat, B., and Jamieson, J. M. (1980) Theoretical model for glomerular filtration of charged solutes. Am. J. Physiol. 238 (2), F126-F139.
25. Snider, J., Neville, C., Yuan, L. C., and Bullock, J. (1992) Characterization of the heterogeneity of poly(ethylene glycol)-modified superoxide dismutase by chromatographic and electrophoretic techniques. J. Chromatogr. 599 (1-2), 141-155.
26. Kanaji, T., Ozaki, H., Takao, T., Kawajiri, H., Ide, H., Motoki, M., and Shimonishi, Y. (1993) Primary structure of microbial transglutaminase from Streptoverticillium sp. strain s-8112. J. Biol. Chem. 268 (16), 11565-11572.
27. Cheng, T. L., Wu, P. Y., Wu, M. F., Chern, J. W., and Steve, R. R. (1999) Accelerated clearance of poly(ethylene glycol)-modified proteins by anti-poly(ethylene glycol) IgM. Bioconjugate Chem. 10, 520-528.